Implementation of WHO's revised drug strategy: rational use of drugs; and WHO'S Action Programme on Essential Drugs: draft resolution proposed by the delegations of Australia, Bahrain, Bangladesh, Belgium, Bhutan, Botswana, Cameroon, Canada, Colombia, Denmark, Eritrea, Finland, France, Georgia, Ghana, Guyana, Hungary, Iceland, Japan, Kazakhstan, Kenya, Lesotho, Lithuania, Malawi, Malaysia, Mongolia, Netherlands, New Zealand, Nicaragua, Niger, Norway, Oman, Pakistan, Qatar, Russian Federation, Slovenia, Spain, Sri Lanka, Sweden, Syrian Arab Republic, Togo, Tunisia, Turkey, Uganda, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, Viet Nam and Zambia

(Agenda item 19)

Bibliographic Details
Main Author: World Health Assembly, 47
Format: Report
Language:English
Published: World Health Organization 1994
Subjects:
Essential medicines
Pharmaceutical products
Drugs
Essential
National Health Programs
Drug Delivery Systems
Program Development
Regional Health Planning
Pharmaceutical Preparations
Drug Industry
Quality Control
prevention and control
standards
utilization
Canada
Norway
New Zealand
Iceland
Online Access:http://www.who.int/iris/handle/10665/177059
id ftwhoiris:oai:localhost:10665/177059
record_format openpolar
spelling ftwhoiris:oai:localhost:10665/177059 2023-05-15T16:48:39+02:00 Implementation of WHO's revised drug strategy: rational use of drugs; and WHO'S Action Programme on Essential Drugs: draft resolution proposed by the delegations of Australia, Bahrain, Bangladesh, Belgium, Bhutan, Botswana, Cameroon, Canada, Colombia, Denmark, Eritrea, Finland, France, Georgia, Ghana, Guyana, Hungary, Iceland, Japan, Kazakhstan, Kenya, Lesotho, Lithuania, Malawi, Malaysia, Mongolia, Netherlands, New Zealand, Nicaragua, Niger, Norway, Oman, Pakistan, Qatar, Russian Federation, Slovenia, Spain, Sri Lanka, Sweden, Syrian Arab Republic, Togo, Tunisia, Turkey, Uganda, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, Viet Nam and Zambia World Health Assembly, 47 Geneva 1994 http://www.who.int/iris/handle/10665/177059 en eng World Health Organization A47/A/Conf.Paper No.3 http://www.who.int/iris/handle/10665/177059 Essential medicines Pharmaceutical products Drugs Essential National Health Programs Drug Delivery Systems Program Development Regional Health Planning Pharmaceutical Preparations Drug Industry Quality Control prevention and control standards utilization Governing body documents 1994 ftwhoiris 2016-04-25T20:15:16Z (Agenda item 19) Report Iceland WHO (World Health Organization): Institutional Repository for Information Sharing (IRIS) Canada Norway New Zealand
institution Open Polar
collection WHO (World Health Organization): Institutional Repository for Information Sharing (IRIS)
op_collection_id ftwhoiris
language English
topic Essential medicines
Pharmaceutical products
Drugs
Essential
National Health Programs
Drug Delivery Systems
Program Development
Regional Health Planning
Pharmaceutical Preparations
Drug Industry
Quality Control
prevention and control
standards
utilization
spellingShingle Essential medicines
Pharmaceutical products
Drugs
Essential
National Health Programs
Drug Delivery Systems
Program Development
Regional Health Planning
Pharmaceutical Preparations
Drug Industry
Quality Control
prevention and control
standards
utilization
World Health Assembly, 47
Implementation of WHO's revised drug strategy: rational use of drugs; and WHO'S Action Programme on Essential Drugs: draft resolution proposed by the delegations of Australia, Bahrain, Bangladesh, Belgium, Bhutan, Botswana, Cameroon, Canada, Colombia, Denmark, Eritrea, Finland, France, Georgia, Ghana, Guyana, Hungary, Iceland, Japan, Kazakhstan, Kenya, Lesotho, Lithuania, Malawi, Malaysia, Mongolia, Netherlands, New Zealand, Nicaragua, Niger, Norway, Oman, Pakistan, Qatar, Russian Federation, Slovenia, Spain, Sri Lanka, Sweden, Syrian Arab Republic, Togo, Tunisia, Turkey, Uganda, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, Viet Nam and Zambia
topic_facet Essential medicines
Pharmaceutical products
Drugs
Essential
National Health Programs
Drug Delivery Systems
Program Development
Regional Health Planning
Pharmaceutical Preparations
Drug Industry
Quality Control
prevention and control
standards
utilization
description (Agenda item 19)
format Report
author World Health Assembly, 47
author_facet World Health Assembly, 47
author_sort World Health Assembly, 47
title Implementation of WHO's revised drug strategy: rational use of drugs; and WHO'S Action Programme on Essential Drugs: draft resolution proposed by the delegations of Australia, Bahrain, Bangladesh, Belgium, Bhutan, Botswana, Cameroon, Canada, Colombia, Denmark, Eritrea, Finland, France, Georgia, Ghana, Guyana, Hungary, Iceland, Japan, Kazakhstan, Kenya, Lesotho, Lithuania, Malawi, Malaysia, Mongolia, Netherlands, New Zealand, Nicaragua, Niger, Norway, Oman, Pakistan, Qatar, Russian Federation, Slovenia, Spain, Sri Lanka, Sweden, Syrian Arab Republic, Togo, Tunisia, Turkey, Uganda, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, Viet Nam and Zambia
title_short Implementation of WHO's revised drug strategy: rational use of drugs; and WHO'S Action Programme on Essential Drugs: draft resolution proposed by the delegations of Australia, Bahrain, Bangladesh, Belgium, Bhutan, Botswana, Cameroon, Canada, Colombia, Denmark, Eritrea, Finland, France, Georgia, Ghana, Guyana, Hungary, Iceland, Japan, Kazakhstan, Kenya, Lesotho, Lithuania, Malawi, Malaysia, Mongolia, Netherlands, New Zealand, Nicaragua, Niger, Norway, Oman, Pakistan, Qatar, Russian Federation, Slovenia, Spain, Sri Lanka, Sweden, Syrian Arab Republic, Togo, Tunisia, Turkey, Uganda, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, Viet Nam and Zambia
title_full Implementation of WHO's revised drug strategy: rational use of drugs; and WHO'S Action Programme on Essential Drugs: draft resolution proposed by the delegations of Australia, Bahrain, Bangladesh, Belgium, Bhutan, Botswana, Cameroon, Canada, Colombia, Denmark, Eritrea, Finland, France, Georgia, Ghana, Guyana, Hungary, Iceland, Japan, Kazakhstan, Kenya, Lesotho, Lithuania, Malawi, Malaysia, Mongolia, Netherlands, New Zealand, Nicaragua, Niger, Norway, Oman, Pakistan, Qatar, Russian Federation, Slovenia, Spain, Sri Lanka, Sweden, Syrian Arab Republic, Togo, Tunisia, Turkey, Uganda, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, Viet Nam and Zambia
title_fullStr Implementation of WHO's revised drug strategy: rational use of drugs; and WHO'S Action Programme on Essential Drugs: draft resolution proposed by the delegations of Australia, Bahrain, Bangladesh, Belgium, Bhutan, Botswana, Cameroon, Canada, Colombia, Denmark, Eritrea, Finland, France, Georgia, Ghana, Guyana, Hungary, Iceland, Japan, Kazakhstan, Kenya, Lesotho, Lithuania, Malawi, Malaysia, Mongolia, Netherlands, New Zealand, Nicaragua, Niger, Norway, Oman, Pakistan, Qatar, Russian Federation, Slovenia, Spain, Sri Lanka, Sweden, Syrian Arab Republic, Togo, Tunisia, Turkey, Uganda, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, Viet Nam and Zambia
title_full_unstemmed Implementation of WHO's revised drug strategy: rational use of drugs; and WHO'S Action Programme on Essential Drugs: draft resolution proposed by the delegations of Australia, Bahrain, Bangladesh, Belgium, Bhutan, Botswana, Cameroon, Canada, Colombia, Denmark, Eritrea, Finland, France, Georgia, Ghana, Guyana, Hungary, Iceland, Japan, Kazakhstan, Kenya, Lesotho, Lithuania, Malawi, Malaysia, Mongolia, Netherlands, New Zealand, Nicaragua, Niger, Norway, Oman, Pakistan, Qatar, Russian Federation, Slovenia, Spain, Sri Lanka, Sweden, Syrian Arab Republic, Togo, Tunisia, Turkey, Uganda, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, Viet Nam and Zambia
title_sort implementation of who's revised drug strategy: rational use of drugs; and who's action programme on essential drugs: draft resolution proposed by the delegations of australia, bahrain, bangladesh, belgium, bhutan, botswana, cameroon, canada, colombia, denmark, eritrea, finland, france, georgia, ghana, guyana, hungary, iceland, japan, kazakhstan, kenya, lesotho, lithuania, malawi, malaysia, mongolia, netherlands, new zealand, nicaragua, niger, norway, oman, pakistan, qatar, russian federation, slovenia, spain, sri lanka, sweden, syrian arab republic, togo, tunisia, turkey, uganda, united kingdom of great britain and northern ireland, united republic of tanzania, viet nam and zambia
publisher World Health Organization
publishDate 1994
url http://www.who.int/iris/handle/10665/177059
op_coverage Geneva
geographic Canada
Norway
New Zealand
geographic_facet Canada
Norway
New Zealand
genre Iceland
genre_facet Iceland
op_relation A47/A/Conf.Paper No.3
http://www.who.int/iris/handle/10665/177059
_version_ 1766038727800389632

Similar Items